赛隆药业(002898.SZ):一季度预亏850万元-1250万元
格隆汇4月14日丨赛隆药业(002898.SZ)披露2020年第一季度业绩预告,预计归属于上市公司股东的净亏损850.00万元-1250.00万元,上年同期盈利314.73 万元。业绩变动原因如下:
1.公司主要产品为注射剂,终端客户为各级医疗机构。新冠肺炎疫情发生后,各级医疗机构的诊疗服务及患者就医计划均受到影响,药品终端需求明显下降。同时,由于疫情期间物流配送、商业推广、各省招投标准入工作受到一定程度限制,公司注射用胸腺法新、阿加曲班注射液、注射用替加环素等2019年底获批的新产品,市场导入尚需要一定时间。
2.报告期内,非经常性损益对利润总额的影响金额约为-52.34万元,主要为:收到政府相关补助101.83万元,公司支持抗疫捐赠等支出154.36万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.